Kidney (Renal Cell) Cancer, Melanoma, Prostate Cancer,
Showing 9976 - 10000 of >10,000
Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance
Not yet recruiting
- Metastatic Leiomyosarcoma
- +5 more
- Computed Tomography
- +3 more
- (no location specified)
Feb 2, 2023
Homologous Recombination Repair Pathway Gene Mutation Spectrum
Not yet recruiting
- Breast Cancer
- (no location specified)
Jun 4, 2023
Lung Cancer Trial in Philadelphia (Framed Introductory Message A, Framed Introductory Message B, Framed Introductory Message C)
Recruiting
- Lung Cancer
- Framed Introductory Message A
- +5 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 25, 2023
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +5 more
- Bevacizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
Neuropathy in Cacer Patien Trial (Duloxetine alone, Duloxetine augmented with gabapentin, Duloxetine augmented with
Not yet recruiting
- Neuropathy in Cacer Patien
- Duloxetine alone
- +2 more
- (no location specified)
Oct 18, 2023
Breast Cancer Stage IV Trial in China (Huaier Granule)
Not yet recruiting
- Breast Cancer Stage IV
- Huaier Granule
-
Shijia Zhuang, Hebei, China
- +12 more
May 12, 2023
Brain Imaging, Nutrition, and Cognition in Breast Cancer
Recruiting
- Breast Cancer
-
Columbus, OhioThe Ohio State University
Oct 5, 2022
Ovarian Cancer, Chemotherapeutic Toxicity Trial in Evanston (Fasting Mimicking Diet (Xentigen by L'Nutra), Carboplatin,
Not yet recruiting
- Ovarian Cancer
- Chemotherapeutic Toxicity
- Fasting Mimicking Diet (Xentigen by L'Nutra)
- +3 more
-
Evanston, IllinoisNorthShore University HealthSystem
Jun 25, 2023
Brain Cancer, Cancer, Solid Tumor Trial in Edmonton (18F-FLT)
Terminated
- Brain Cancer
- +3 more
- 18F-FLT
-
Edmonton, Alberta, CanadaCross Cancer Institute
Aug 21, 2019
Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;
Recruiting
- Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
- dalpiciclib; fluvestrant; compound gossypol acetate tablets
-
Hangzhou, Zhejiang, ChinazhejiangCH
Nov 9, 2023
Solid Tumor Spine Metastases Trial in Dublin (Radiation: image guided dose escalated SABR using a simultaneous integrated boost
Not yet recruiting
- Solid Tumor Spine Metastases
- Radiation: image guided dose escalated SABR using a simultaneous integrated boost (SIB)
-
Dublin, Ireland
- +1 more
Oct 16, 2023
Danish Assessment of Minimal Residual Disease by Liquid Biopsies
Recruiting
- Colorectal Neoplasms
- +5 more
-
Copenhagen, Capital Region Of Denmark, Denmark
- +8 more
Oct 13, 2023
Omitting Axillary Surgery in Breast Cancer Isolated Chest Wall
Recruiting
- Breast Cancer
- Recurrent Disease
- axillary surgery
-
Singapore, SingaporeKK Women's and Children's Hospital
Oct 12, 2023
Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,
Not yet recruiting
- Metastatic Uveal Melanoma
- Metastatic Cutaneous Melanoma
- Autologous Tumor Infiltrating Lymphocytes
- +2 more
- (no location specified)
Oct 14, 2022
Advanced Malignant Tumor, Delirium, Locally Advanced Malignant Tumor Trial in Houston (Chlorpromazine, Haloperidol,
Active, not recruiting
- Advanced Malignant Neoplasm
- +4 more
- Chlorpromazine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Vitamin D Deficiency Trial in Jamshoro (Soft gelatin 200000 IU vitamin D3 capsule, Orodispersible (sachet) 200000 IU vitamin D3)
Enrolling by invitation
- Vitamin D Deficiency
- Soft gelatin 200000 IU vitamin D3 capsule
- Orodispersible (sachet) 200000 IU vitamin D3
-
Jamshoro, Sindh, PakistanLiaquat Medical University Hospital
Jan 20, 2023
Pancreatic Cancer Trial in Guangzhou (TCR-T therapy)
Recruiting
- Pancreatic Cancer
- TCR-T therapy
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Aug 10, 2022
Brain Cancer, Cognitive Impairment Trial (ImPACT program)
Not yet recruiting
- Brain Cancer
- Cognitive Impairment
- ImPACT program
- (no location specified)
May 11, 2023
Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)
Recruiting
- Breast Cancer
- Docetaxel
- +6 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022
Advanced Lung Non-Small Cell Carcinoma, Advanced Lung Small Cell Carcinoma, Extensive Stage Lung Small Cell Carcinoma Trial in
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +9 more
- Best Practice
- +5 more
-
Columbus, OhioCarolyn Presley
Aug 30, 2022
Cancer Trial in Pittsburgh (Dose esclated resistance training)
Recruiting
- Cancer
- Dose esclated resistance training
-
Pittsburgh, PennsylvaniaAHN CI Exercise Oncology and Resiliency Center
Oct 9, 2023
Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)
Not yet recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
Cancer-Related Pain Trial in Philadelphia (Use of buprenorphine with FAO > 30 OME, CPM Rx application use)
Recruiting
- Cancer-Related Pain
- Use of buprenorphine with FAO > 30 OME
- CPM Rx application use
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jun 9, 2023
Patients Undergoing CAR-T Cell Therapy (CAR_21_01)
Recruiting
- CAR-T Therapy Complications
-
Bologna, ItalyIRCC, University Hospital of Bologna
Mar 18, 2022
Prostate Cancer Trial in Houston (Ipilimumab, Leuprolide, Goserelin)
Terminated
- Prostate Cancer
- Ipilimumab
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 16, 2019